SCHEMBL22280709

SCHEMBL22280709

COc1ccc2c3ccc(-c4c(C)cc(C)cc4C)nc3n3c4ccccc4nc3c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 2/20 0.42
PDE10A Q9Y233 2/20 0.42
POLB P06746 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 6/20 0.40
KDM4E B2RXH2 4/20 0.40
TP53 P04637 3/20 0.40
HSD17B10 Q99714 3/20 0.40
LMNA P02545 1/20 0.40
FLT3 P36888 1/20 0.40
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
CASP1 P29466 1/20 0.38
MEN1 O00255 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 1/20 0.38
JAK2 O60674 1/20 0.38
ATM Q13315 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280944 0.92 KDM4E (0.41) POLBNPSR1MAPTKDM4ETP53
SCHEMBL22281210 0.88 KDM4E (0.41) POLBNPSR1MAPTKDM4ETP53
SCHEMBL22280712 0.85 PDE2A (0.43) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL22281100 0.83 PDE2A (0.43) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL22280938 0.83 PDE2A (0.43) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL21917497 0.78 MAPT (0.51) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL21917619 0.78 POLB (0.45) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL22280896 0.76 ALDH1A1 (0.34) POLBNPSR1MAPTKDM4EHSD17B10
SCHEMBL21917622 0.76 POLB (0.48) PDE2APDE10APOLBNPSR1MAPT
SCHEMBL21917584 0.75 POLB (0.47) PDE2APDE10APOLBNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES EML4, TYR, TYMP PDE2A 2001/4885PDE10A 2335/4885POLB 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.